Medications
Breast cancer 'signature' predicts response to new drug class
Melbourne researchers have developed a new way to pinpoint which breast cancers will respond to a new class of anti-cancer agents called Smac-mimetics.
May 6, 2020
0
272
Page 6 - Walter and Eliza Hall Institute of Medical Research
Medications
Cancer drugs show promise in preventing malaria
A potential new approach for preventing malaria is on the horizon with the discovery that drugs currently used to kill cancer cells can also kill malaria-infected liver cells.
Apr 1, 2020
0
110
Oncology & Cancer
New technology helps in hunt for new cancer drug combinations
A revolutionary new technology has been applied to reveal the inner workings of individual cancer cells—potentially identifying more effective treatment combinations for people with cancer.
Mar 19, 2020
0
6
Medical research
Novel compound sparks new malaria treatment hope
A novel class of antimalarial compounds that can effectively kill malaria parasites has been developed by Australian and US researchers.
Mar 4, 2020
0
56
Medical research
New front opened in fight against common cancer driver
Walter and Eliza Hall Institute researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells.
Feb 20, 2020
0
8
Medical research
Suspect eliminated as a therapeutic target in B cell lymphoma
Walter and Eliza Hall Institute researchers have narrowed the focus on which survival proteins are important for the survival of B cell lymphomas, eliminating the protein BCL-W from the "suspect list."
Feb 5, 2020
0
31
Genetics
New genetic cause of epilepsy found
Researchers from the Walter and Eliza Hall Institute have contributed to a decades-long global effort that has revealed two new gene mutations that cause a rare type of epilepsy.
Dec 9, 2019
0
176
Neuroscience
Tiny blood cells could protect against cerebral palsy
Platelets—tiny cells critical for blood clotting—could be the key to protecting against brain damage occurring during pregnancy or around the time of birth.
Aug 2, 2019
0
3
Oncology & Cancer
Melanoma patient outcomes predicted by computational biology
Walter and Eliza Hall Institute researchers have used computational biology to discover a "gene signature" that identifies a group of melanoma patients with improved rates of survival.
Jun 25, 2019
0
0
Genetics
Waking 'sleeping genes' could help Prader-Willi syndrome
New funding is enabling Walter and Eliza Hall Institute researchers to develop new approaches to potentially help people with Prader-Willi syndrome, a devastating and incurable genetic condition.
May 20, 2019
0
1508
